Nu Skin Enterprises Net Income
| NUS Stock | USD 8.36 1.85 18.12% |
As of the 14th of February 2026, Nu Skin owns the Market Risk Adjusted Performance of (0.22), information ratio of (0.08), and Mean Deviation of 2.03. In relation to fundamental indicators, the technical analysis model lets you check practical technical drivers of Nu Skin Enterprises, as well as the relationship between them. Please verify Nu Skin Enterprises market risk adjusted performance and treynor ratio to decide if Nu Skin Enterprises is priced correctly, providing market reflects its prevailing price of 8.36 per share. Given that Nu Skin Enterprises has information ratio of (0.08), we recommend you to check Nu Skin's latest market performance to make sure the company can sustain itself at some point in the future.
Nu Skin Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.3436 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 160.2 M | 115.9 M | |
| Net Loss | -168.6 M | -160.2 M | |
| Net Loss | -131.9 M | -125.3 M | |
| Net Income Per Share | 3.25 | 3.41 | |
| Net Income Per E B T | 0.82 | 0.53 |
NUS | Net Income | Build AI portfolio with NUS Stock |
The evolution of Net Income for Nu Skin Enterprises provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Nu Skin compares to historical norms and industry peers.
Latest Nu Skin's Net Income Growth Pattern
Below is the plot of the Net Income of Nu Skin Enterprises over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Nu Skin Enterprises financial statement analysis. It represents the amount of money remaining after all of Nu Skin Enterprises operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Nu Skin's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nu Skin's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 160.2 M | 10 Years Trend |
|
Net Income |
| Timeline |
NUS Net Income Regression Statistics
| Arithmetic Mean | 132,455,687 | |
| Coefficient Of Variation | 78.91 | |
| Mean Deviation | 65,057,897 | |
| Median | 143,086,000 | |
| Standard Deviation | 104,515,450 | |
| Sample Variance | 10923.5T | |
| Range | 511.5M | |
| R-Value | (0.41) | |
| Mean Square Error | 9659.8T | |
| R-Squared | 0.17 | |
| Significance | 0.1 | |
| Slope | (8,557,602) | |
| Total Sum of Squares | 174775.7T |
NUS Net Income History
Other Fundumenentals of Nu Skin Enterprises
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Nu Skin Net Income component correlations
NUS Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Nu Skin is extremely important. It helps to project a fair market value of NUS Stock properly, considering its historical fundamentals such as Net Income. Since Nu Skin's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nu Skin's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nu Skin's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Personal Care Products market expansion? Will NUS introduce new products? Factors like these will boost the valuation of Nu Skin. Anticipated expansion of NUS directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Nu Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.036 | Dividend Share 0.24 | Earnings Share 2.19 | Revenue Per Share | Quarterly Revenue Growth (0.15) |
Nu Skin Enterprises's market price often diverges from its book value, the accounting figure shown on NUS's balance sheet. Smart investors calculate Nu Skin's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Nu Skin's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Nu Skin's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nu Skin should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Nu Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Nu Skin 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nu Skin's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nu Skin.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Nu Skin on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Nu Skin Enterprises or generate 0.0% return on investment in Nu Skin over 90 days. Nu Skin is related to or competes with Helen Of, Beyond Meat, MGP Ingredients, Village Super, Above Food, American Public, and Lincoln Educational. Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide More
Nu Skin Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nu Skin's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nu Skin Enterprises upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 14.3 | |||
| Value At Risk | (4.44) | |||
| Potential Upside | 3.81 |
Nu Skin Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nu Skin's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nu Skin's standard deviation. In reality, there are many statistical measures that can use Nu Skin historical prices to predict the future Nu Skin's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.44) | |||
| Treynor Ratio | (0.23) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nu Skin's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nu Skin February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.22) | |||
| Mean Deviation | 2.03 | |||
| Coefficient Of Variation | (1,802) | |||
| Standard Deviation | 3.32 | |||
| Variance | 11.02 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.44) | |||
| Treynor Ratio | (0.23) | |||
| Maximum Drawdown | 14.3 | |||
| Value At Risk | (4.44) | |||
| Potential Upside | 3.81 | |||
| Skewness | (2.52) | |||
| Kurtosis | 12.71 |
Nu Skin Enterprises Backtested Returns
Nu Skin Enterprises retains Efficiency (Sharpe Ratio) of -0.0413, which conveys that the firm had a -0.0413 % return per unit of price deviation over the last 3 months. Nu Skin exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nu Skin's Mean Deviation of 2.03, market risk adjusted performance of (0.22), and Information Ratio of (0.08) to check out the risk estimate we provide. The company owns a Beta (Systematic Risk) of 0.86, which conveys possible diversification benefits within a given portfolio. Nu Skin returns are very sensitive to returns on the market. As the market goes up or down, Nu Skin is expected to follow. At this point, Nu Skin Enterprises has a negative expected return of -0.14%. Please make sure to verify Nu Skin's treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if Nu Skin Enterprises performance from the past will be repeated at future time.
Auto-correlation | 0.31 |
Below average predictability
Nu Skin Enterprises has below average predictability. Overlapping area represents the amount of predictability between Nu Skin time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nu Skin Enterprises price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current Nu Skin price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.31 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.38 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
NUS Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Nu Skin Enterprises reported net income of 160.2 M. This is 85.51% lower than that of the Personal Care Products sector and 84.02% lower than that of the Consumer Staples industry. The net income for all United States stocks is 71.94% higher than that of the company.
NUS Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nu Skin's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nu Skin could also be used in its relative valuation, which is a method of valuing Nu Skin by comparing valuation metrics of similar companies.Nu Skin is currently under evaluation in net income category among its peers.
Nu Skin ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Nu Skin's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Nu Skin's managers, analysts, and investors.Environmental | Governance | Social |
Nu Skin Institutional Holders
Institutional Holdings refers to the ownership stake in Nu Skin that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Nu Skin's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Nu Skin's value.| Shares | Two Sigma Advisers, Llc | 2025-06-30 | 933.5 K | Castleknight Management Lp | 2025-06-30 | 890.8 K | Jpmorgan Chase & Co | 2025-06-30 | 764.1 K | Goldman Sachs Group Inc | 2025-06-30 | 737.1 K | Hillsdale Investment Management Inc. | 2025-06-30 | 660.7 K | Two Sigma Investments Llc | 2025-06-30 | 638.7 K | Prudential Financial Inc | 2025-06-30 | 601.7 K | Bank Of New York Mellon Corp | 2025-06-30 | 585.7 K | Aristotle Capital Boston, Llc | 2025-06-30 | 511 K | Vanguard Group Inc | 2025-06-30 | 4.1 M | Blackrock Inc | 2025-06-30 | 4.1 M |
NUS Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0412 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 536.17 M | ||||
| Shares Outstanding | 48.75 M | ||||
| Shares Owned By Insiders | 2.19 % | ||||
| Shares Owned By Institutions | 78.25 % | ||||
| Number Of Shares Shorted | 2.31 M | ||||
| Price To Earning | 10.70 X | ||||
| Price To Book | 0.62 X | ||||
| Price To Sales | 0.26 X | ||||
| Revenue | 1.49 B | ||||
| Gross Profit | 1.09 B | ||||
| EBITDA | 65.76 M | ||||
| Net Income | 160.2 M | ||||
| Cash And Equivalents | 186.88 M | ||||
| Cash Per Share | 7.69 X | ||||
| Total Debt | 281.83 M | ||||
| Debt To Equity | 0.59 % | ||||
| Current Ratio | 2.30 X | ||||
| Book Value Per Share | 16.29 X | ||||
| Cash Flow From Operations | 80.29 M | ||||
| Short Ratio | 5.59 X | ||||
| Earnings Per Share | 2.19 X | ||||
| Price To Earnings To Growth | 2.35 X | ||||
| Target Price | 7.5 | ||||
| Number Of Employees | 3.1 K | ||||
| Beta | 0.99 | ||||
| Market Capitalization | 476.78 M | ||||
| Total Asset | 1.41 B | ||||
| Retained Earnings | 1.86 B | ||||
| Working Capital | 241.99 M | ||||
| Current Asset | 706.39 M | ||||
| Current Liabilities | 407.6 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 3.09 % | ||||
| Net Asset | 1.41 B | ||||
| Last Dividend Paid | 0.24 |
About Nu Skin Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nu Skin Enterprises's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nu Skin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nu Skin Enterprises based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NUS Stock Analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.